190792-75-7 Usage
Description
1-Pyrrolidinecarboxylic acid, 3-amino-4-hydroxy-, 1,1-dimethylethyl ester, (3S-cis)-(9CI) is a chiral chemical compound with the molecular formula C9H18N2O3. It is a derivative of the amino acid proline and is commonly known as tert-butyl (3S)-cis-4-amino-3-hydroxy-1-pyrrolidinecarboxylate. 1-Pyrrolidinecarboxylicacid,3-amino-4-hydroxy-,1,1-dimethylethylester,(3S-cis)-(9CI) has potential pharmaceutical applications as a chiral building block for the synthesis of various pharmaceutical drugs.
Uses
Used in Pharmaceutical Industry:
1-Pyrrolidinecarboxylic acid, 3-amino-4-hydroxy-, 1,1-dimethylethyl ester, (3S-cis)-(9CI) is used as a chiral building block for the synthesis of various pharmaceutical drugs. Its unique structure and properties make it a valuable component in the development of new medications.
Used in Organic Synthesis:
1-Pyrrolidinecarboxylicacid,3-amino-4-hydroxy-,1,1-dimethylethylester,(3S-cis)-(9CI) is also used in organic synthesis, where it serves as a reagent in chemical reactions. Its versatility and reactivity contribute to the synthesis of a wide range of organic compounds.
Used in Research and Development:
1-Pyrrolidinecarboxylic acid, 3-amino-4-hydroxy-, 1,1-dimethylethyl ester, (3S-cis)-(9CI) has been studied for its potential use in the treatment of certain medical conditions, such as cardiovascular disease and cancer. Its unique properties and potential therapeutic effects make it a promising candidate for further research and development in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 190792-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,7,9 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 190792-75:
(8*1)+(7*9)+(6*0)+(5*7)+(4*9)+(3*2)+(2*7)+(1*5)=167
167 % 10 = 7
So 190792-75-7 is a valid CAS Registry Number.
190792-75-7Relevant articles and documents
Guanidine derivative and application thereof
-
Paragraph 0307; 0309-0312, (2020/06/09)
The invention relates to a guanidine derivative serving as a VAP-1 inhibitor and application of the guanidine derivative, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be us
FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0412-0413, (2019/10/10)
Provided are a class of compounds as shown in formula (I) as FGFR4 inhibitors, and pharmaceutically acceptable salts thereof, preparation methods therefor and the use thereof in the preparation of drugs for treating FGFR4-related diseases.
INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE
-
Page/Page column 157, (2018/06/30)
Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').
